Search

Your search keyword '"Pelttari, Liisa M"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Pelttari, Liisa M" Remove constraint Author: "Pelttari, Liisa M" Database Unpaywall Remove constraint Database: Unpaywall
41 results on '"Pelttari, Liisa M"'

Search Results

1. Supplementary Table 5 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

2. Supplementary Table 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

3. Data from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

4. Supplementary Table 5 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

5. Supplementary Table 2 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

6. Supplementary Table 3 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

7. Data from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

8. Supplementary Table 4 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

9. Data from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

10. Supplementary Figure 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

11. Supplementary Table 4 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

12. Supplementary Table 2 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

13. Supplementary Tables S1-6, Figures S1-2 from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

14. Supplementary Tables S1-6, Figures S1-2 from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

15. Supplementary Table 3 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

16. Supplementary Table 1 from HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

17. Data from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

18. Data from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

19. Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

20. Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

21. Data from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

22. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

23. Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients

24. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

26. FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population

27. FANCMc.5101C>T mutation associates with breast cancer survival and treatment outcome

28. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

29. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

30. Evidence of a genetic link between endometriosis and ovarian cancer

32. Abstract P4-12-03: Triple-negative breast cancer: Frequency of inherited mutations in breast cancer susceptibility genes

33. Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

35. Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

36. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer

37. HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

39. A Finnish founder mutation inRAD51D: analysis in breast, ovarian, prostate, and colorectal cancer: Table 1

41. RAD51C is a susceptibility gene for ovarian cancer

Catalog

Books, media, physical & digital resources